George Harrison Talbot Net Worth & Insider Trades
George Harrison Talbot - Director, Nabriva Therapeutics Plc
What is George Harrison Talbot's Net Worth?
The current estimated net worth of Nabriva Therapeutics Plc's Director, George Harrison Talbot, is estimated to be about $98.07K . George Harrison Talbot owns about 47,640 units of Nabriva Therapeutics Plc common stock. In the last year at Nabriva Therapeutics Plc, George Harrison Talbot has sold an estimated value of $69.79K worth.
What is George Harrison Talbot's Past Insider Trading?
George Harrison Talbot's largest purchase order was 14,500 units , worth over $39.88K on August 2, 2018. George Harrison Talbot's largest sale order was 325 units , worth over $32.68K on May 25, 2017. In total, George Harrison Talbot has made about 5 transactions over a year of their time at Nabriva Therapeutics Plc. George Harrison Talbot usually trades in June, with the busiest year in 2017.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Harrison George Talbot
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is George Harrison Talbot's' Mailing Address?
- Mailing address is C/o Durata Therapeutics, Inc. 89 Headquarters Plaza North, 14th Floor Morristown NJ 07960 NJ
Nabriva Therapeutics Plc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Other Earnings Plans or Compensations
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Theodore Schroeder | 2020 | $576,800 | - | $242,256 | $339,625 | $242,256 | $31,759 | $1,654,570 |
| Theodore Schroeder | 2019 | $560,000 | - | $119,250 | $478,367 | $119,250 | $28,372 | $1,496,164 |
| Steven Gelone | 2020 | $486,300 | - | $153,185 | $231,493 | $153,185 | $12,675 | $1,154,516 |
| Steven Gelone | 2019 | $472,100 | - | $181,420 | $309,859 | $181,420 | $13,976 | $1,178,280 |
| Jennifer Schranz | 2020 | $460,000 | $100,000 | $145,203 | $156,818 | $145,203 | $28,604 | $1,074,113 |
| Jennifer Schranz | 2019 | $436,200 | - | $151,200 | $261,555 | $151,200 | $33,450 | $982,155 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1641640/000110465921088033/tm2119969-2_def14a.htm
What are Nabriva Therapeutics Plc's Past Insider Trades?
Nabriva Therapeutics Plc's most recent insider trade came on August 4, 2022 by Daniel Burgess who sold 11,341 units worth $2.16K . In the last 5 years, insiders at Nabriva Therapeutics Plc have sold an estimated value of $5.26M and bought an estimated value of $1.22M worth of shares. Insider trading is most common in August, with the busiest year in 2021. The most active traders at the company are Steven Gelone, Director, Theodore Schroeder, Director, and Robert Crotty, Gen Counsel & Corp Secretary .
Nabriva Therapeutics Legacy plc Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||